Disclosures: Michael Thornton: ENDRA Life Sciences Inc: Employee, Jang Hwan Cho: Endra Life Sciences, Inc.: Employee, Idan Steinberg: Nothing to Disclose, Jing Gao: Nothing to Disclose, Colby Adamson: Nothing to Disclose 838 DIFFERENTIAL IMPACTS OF GLP1R GENE VARIANTS ON DISEASE RISK AND TREATMENT EFFICACY IN AFRICAN AMERICANS Eleonora Scorletti 1 Helen Huang 1 David Zhang 1 Marijana Vujkovic 1 Joseph Park 1 Florian Kahles 2 Giorgio Sirugo 1 Michael Phillips 1 Kai Markus Schneider 2 Garret FitzGerald 1 Daniel Rader 1 Carolin Schneider 2 , 1 University of Pennsylvania, 2 University of Aachen Background: Previous studies in European cohorts have established associations between single nucleotide polymorphisms (SNPs) in the glucagon-like peptide 1 receptor gene (GLP1R) and both obesity and type 2 diabetes (T2D), conditions characterized by a fundamental insulin resistance
It's important for patients to be aware that this formulation may interact with certain medications, including anticoagulants, anticonvulsants, antibiotics, and antifungals
The plate was incubated at room temperature for 510 min, before luminescence was measured using a Victor 3 1420 Multilabel Counter (Wallac 1420 Workstation, version 3.00 revision 5
We have focused on AS (radiographic axSpA) since it is both clinically and genetically much more homogeneous than nr-axSpA
